Sara M. Wilchowski, DMSc, MPAS, PA-C

home / authors / sara-m-wilchowski-dmsc-pa-c

Articles

From Clinic to Industry: Insights Into the MSL Role and PA Advocacy

Kaitlyn Bader, Assistant Managing Editor;Sara M. Wilchowski, DMSc, MPAS, PA-C

November 16th 2024

At the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.

Alternative Care Options for Inflammatory Diseases

Sara M. Wilchowski, DMSc, MPAS, PA-C

June 7th 2023

Considering the whole patient is crucial in understanding how natural alternatives can improve the skin.

Sara’s Skin Security: Arm Them With Knowledge

Sara M. Wilchowski, DMSc, MPAS, PA-C

May 1st 2023

Discussing photoprotection with patients is crucial as “Melanoma May" kicks off this month.

10 Things I Wish My Patients Knew About Atopic Dermatitis

Sara M. Wilchowski, DMSc, MPAS, PA-C

February 3rd 2023

Atopic dermatitis is not a "one-size-fits-all" condition.

Latest Updated Articles

Published: September 19th 2024 | Updated: September 26th 2024

Final Thoughts: The Importance of Comparative Studies in AD

Published: June 6th 2023 | Updated: May 6th 2025

POLL: What Percentage of the Population Has Hidradenitis Suppurativa?

Published: April 29th 2025 | Updated: May 6th 2025

FDA Approves First Gene Therapy for RDEB

$FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria$

Published: April 18th 2025 | Updated: May 6th 2025

FDA Approves Dupilumab for Adolescents and Adults With H1 Antihistamine-Refractory Chronic Spontaneous Urticaria

Published: April 22nd 2025 | Updated: May 6th 2025

Using Real-World AD Cases to Pick the Right Therapy for Each Patient

Published: April 1st 2025 | Updated: May 6th 2025

Optimizing Vitiligo Care: Key Expert Takeaways